全文获取类型
收费全文 | 2407篇 |
免费 | 174篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 88篇 |
妇产科学 | 26篇 |
基础医学 | 238篇 |
口腔科学 | 47篇 |
临床医学 | 248篇 |
内科学 | 474篇 |
皮肤病学 | 57篇 |
神经病学 | 57篇 |
特种医学 | 289篇 |
外科学 | 354篇 |
综合类 | 72篇 |
一般理论 | 1篇 |
预防医学 | 134篇 |
眼科学 | 56篇 |
药学 | 107篇 |
中国医学 | 11篇 |
肿瘤学 | 321篇 |
出版年
2023年 | 9篇 |
2021年 | 13篇 |
2020年 | 20篇 |
2019年 | 28篇 |
2018年 | 35篇 |
2017年 | 31篇 |
2016年 | 31篇 |
2015年 | 47篇 |
2014年 | 59篇 |
2013年 | 101篇 |
2012年 | 94篇 |
2011年 | 100篇 |
2010年 | 72篇 |
2009年 | 100篇 |
2008年 | 95篇 |
2007年 | 126篇 |
2006年 | 86篇 |
2005年 | 97篇 |
2004年 | 62篇 |
2003年 | 73篇 |
2002年 | 76篇 |
2001年 | 58篇 |
2000年 | 74篇 |
1999年 | 74篇 |
1998年 | 94篇 |
1997年 | 73篇 |
1996年 | 80篇 |
1995年 | 53篇 |
1994年 | 57篇 |
1993年 | 55篇 |
1992年 | 45篇 |
1991年 | 38篇 |
1990年 | 49篇 |
1989年 | 65篇 |
1988年 | 41篇 |
1987年 | 53篇 |
1986年 | 38篇 |
1985年 | 31篇 |
1984年 | 28篇 |
1983年 | 25篇 |
1982年 | 21篇 |
1981年 | 26篇 |
1980年 | 16篇 |
1979年 | 13篇 |
1978年 | 10篇 |
1977年 | 18篇 |
1976年 | 12篇 |
1975年 | 15篇 |
1973年 | 9篇 |
1966年 | 10篇 |
排序方式: 共有2598条查询结果,搜索用时 15 毫秒
51.
52.
Flora Maria Lorenzo Fortes Ney Boa Sorte Victor D Mariano La la D Andrade Fernanda A Oliveira Monique CA Santos Cl udia Ivanilda N dos Santos Catharina A Passos Mila P Pacheco Valdiana C Surlo Neog lia P de Almeida Jaciane AM Fontes r a M Pimentel Raquel Rocha Genoile Oliveira Santana 《World journal of gastroenterology : WJG》2020,26(44):6993-7004
BACKGROUNDThere has been an increase in cases of inflammatory bowel disease (IBD) in recent years. There is also greater access and availability of immunosuppressive and biological agents, which increase the risk of opportunistic infection despite improving the quality of life and promoting mucosal healing. Tuberculosis (TB) remains a public health problem, and it has a high incidence in several countries. Therefore, knowledge of the risk of developing TB in patients with IBD is important.AIMTo evaluate the risk of active TB in patients with IBD under treatment from an endemic area in Latin America.METHODSA standard questionnaire included demographic variables, clinical aspects of IBD disease, history of active TB during treatment, active TB characteristics and evolution, initial screening and results and time from the start of anti-tumor necrosis factor alpha (TNFα) to TB development.RESULTSAzathioprine, anti-TNFα and the combination of these two drugs were associated with a higher risk of active TB incidence. The TNFα blockers increased the relative risk of developing active TB compared to other treatments. All four multivariable models showed that the use of TNFα blockers alone or in combination with azathioprine was an important risk factor for the incidence of active TB. After adjustment for sex, age, type of IBD and latent TB, anti-TNFα with azathioprine increased the relative risk to 17.8 times more than conventional treatment. Late TB, which was diagnosed 3 mo after the start of anti-TNFα, was the most frequent.CONCLUSIONTreatment with anti-TNFα increased the risk of active TB in IBD patients from an endemic area in Latin America. This risk was increased when anti-TNFα was combined with azathioprine. The time from the beginning of the treatment to the active TB diagnosis suggests a new TB infection. 相似文献
53.
54.
55.
56.
57.
Rapid prenatal diagnosis of beta thalassemia using DNA amplification and nonradioactive probes 总被引:3,自引:0,他引:3
We used in vitro DNA amplification by the polymerase chain reaction and nonradioactive probes for prenatal diagnosis of beta thalassemia in Chinese from the Guangdong province. Exact molecular diagnoses were made in all 20 fetuses studied over a 6-month period. We conclude that this method of prenatal diagnosis for beta thalassemia is a viable approach in many parts of the world where this disease is common. 相似文献
58.
Two patients with hairy cell leukemia with massive splenomegaly and severe pancytopenia were treated with recombinant alpha-A interferon (IFN-alpha-2a). There was no significant response to a trial of IFN- alpha-2a (11 and 20 weeks) with respect to blood counts or spleen size. Subsequent treatment with 2'-deoxycoformycin (dCF) for 8 consecutive weeks (4 mg/m2/wk) resulted in normalization of spleen size and a normalization of peripheral blood counts and bone marrow in one patient. The second patient demonstrated a reduction in spleen size and improved blood counts following 9 weeks of dCF therapy but eventually became refractory. This demonstrates that dCF is non-cross-resistant with interferon and confirms the efficacy of dCF in nonsplenectomized patients. 相似文献
59.
Aroni Maurício Andrés Tinajero de Oliveira Guilherme José Pimentel Lopes Spolidório Luís Carlos Andersen Ole Zoffmann Foss Morten Marcantonio Rosemary Adriana Chiérici Stavropoulos Andreas 《Clinical oral investigations》2019,23(4):1605-1614
Clinical Oral Investigations - To evaluate the effect of grafting with strontium (Sr)-loaded deproteinized bovine bone (DBB) on bone healing in calvarial critical size defects (CSD) in rats. Two... 相似文献
60.
Mona Nysted Olav A Foss Jomar Klaksvik P?l Benum Kristin Haugan Otto Schnell Husby Arild Aamodt 《Acta orthopaedica》2014,85(2):152-158